Article: ASCEND Therapeutics Files Patent Applications for Drug Planned to Treat Benign Breast Disease; Patents Expand Intellectual Property of ASCEND's Unique Gel-Based Approach to the Treatment of Benign Breast Disease.

HERNDON, Va., Aug. 12 /PRNewswire/ -- ASCEND Therapeutics today announced that it has filed a patent application for both the pharmaceutical composition of TamoGel(TM) (4-hydroxytamoxifen gel) and the gel's use for the treatment of benign breast disease.

The patents provide protection for ASCEND's transdermal approach to the treatment of chronic conditions like benign breast disease, and solidify the company's proprietary technology position within the breast health therapy market.

Each year approximately 3 million women will experience a first incidence of benign breast disease. The term benign breast disease encompasses a number of nonproliferative ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!